Form D · Biotechnology
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Phoenix, AZ · CIK 0001187953
Offering snapshot reported May 5, 2022 · SEC filing
- Reported sold
- $17M Offering amount: $17M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 3, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 5, 2022 | Initial | $17,000,001 | No comparison | 18 | SEC filing |
| Aug 27, 2021 | Initial | $3,787,750 | No comparison | 17 | SEC filing |
| Sep 28, 2018 | Initial | $509,028 | No comparison | 3 | SEC filing |
| Mar 27, 2018 | Initial | $115,000 | No comparison | 1 | SEC filing |
| Mar 27, 2018 | Initial | $27,500 | No comparison | 1 | SEC filing |
| Mar 27, 2018 | Initial | $48,000 | No comparison | 1 | SEC filing |
| Mar 27, 2018 | Initial | $44,000 | No comparison | 1 | SEC filing |
| Mar 2, 2018 | Initial | $30,000 | No comparison | 1 | SEC filing |
| Mar 2, 2018 | Initial | $53,000 | No comparison | 1 | SEC filing |
| Dec 8, 2017 | Initial | $58,000 | No comparison | 1 | SEC filing |
| Sep 6, 2017 | Initial | $55,000 | No comparison | 1 | SEC filing |
| May 11, 2017 | Initial | $115,000 | No comparison | 1 | SEC filing |
| May 11, 2017 | Initial | $55,000 | No comparison | 1 | SEC filing |
| May 8, 2017 | Initial | $405,000 | No comparison | 1 | SEC filing |
| Apr 17, 2017 | Initial | $100,000 | No comparison | 1 | SEC filing |
| Mar 28, 2017 | Initial | $100,000 | No comparison | 1 | SEC filing |
| May 23, 2016 | Initial | $0 | No comparison | 32 | SEC filing |
| Aug 11, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.36M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-444592
Issued a warrant to purchase 1,133,333 shares of common stock.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Roth Capital Partners | 15407 | Roth Capital Partners · CRD 15407 |
Source: Form D, filed May 5, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Donald Dickerson | Director, Executive |
| Michael H. Finger | Director |
| Thomas Ichim | Director |
| Annette Marleau | Executive |
| Amit Patel | Director |
| Susan Snow | Director |
| Bruce S. Urdang | Director |
| Timothy Warbington | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
211 E. Osborn Rd.
Phoenix, AZ, 85012
Phoenix, AZ, 85012